BioCentury
ARTICLE | Clinical News

Celgene regulatory update

October 16, 1995 7:00 AM UTC

The FDA approved a request from the Warren, N.J., company to recover costs of providing its experimental thalidomide drug, Synovir, to treat cachexia in AIDS patients. The product costs $550 for a 12...